ESI vs REGN · P/E 64, rev $2.46B vs P/E 14, rev $14.34B
Element Solutions Inc (ESI) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Element Solutions Inc (ESI) is a specialty chemicals company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ESI revenue for 2024-12-31 was $2.46B. Net income was $244.5M. Revenue was up 5.3% from 2023-12-31 to 2024-12-31. ESI currently screens at market cap $9.71B and trailing P/E 64.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ESI currently screens at market cap $9.71B and trailing P/E 64.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ESI and REGN stock pages for the full models.
Not investment advice.